Iktos and Zealand Pharma to develop AI technology for peptide drug design
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process
Subscribe To Our Newsletter & Stay Updated